Renal Pathology Society (DOC)

Document Sample
Renal Pathology Society (DOC) Powered By Docstoc
					RPS Bylaws RPS Application Form Awards Bestowed by the RPS

Information for Members

Nephropathology Training Programs RPS Officers Presentations and Speakers at RPS Sponsored Scientific and Educational Sessions

The most important tool of the Communication and Publications Committee of the Renal Pathology Society is the RPS web-site. The objective of the site is to facilitate communication between the members of the RPS, and between the RPS other societies. To this effect, the web-site includes the directory of members with data regarding their areas of research interest - "yellow pages". Collaborative studies and surveys are posted, to ensure continuous availability. Visit the web-site at http://www.renalpathsoc.org/ and learn more about the history of the society, the upcoming international meetings or courses, the opportunities available, the composition of the committees. The Committee is pleased to have available two further services: upon request, electronic messages can be disseminated to all the members (contact ssmith1@tulane.edu) and an electronic discussion group for renal pathology is available at NEPHNPT (contact Kim.Solez@ualberta.ca). Suzanne Meleg-Smith, MD Chair, Communication and Publications Committee

BYLAWS OF RENAL PATHOLOGY SOCIETY, INC (Incorporation version, 3/96, modified 11/97, 3/03, 4/04, 11/04) Article I Name: Renal Pathology Society, Inc. Article II Objectives: The objectives of the Society are to disseminate and to increase knowledge about the pathology and pathophysiology of the kidney, and to encourage the development of renal pathology as a subspecialty. Article III Membership: A. Categories of Membership: 1. Regular Member Any holder of a MD, PhD, DVM, or equivalent degree with demonstrated interest and involvement in the field of renal pathology as determined by the Membership Committee using criteria agreed upon by the Board of Directors. 2. Emeritus Member A member over age 65 may become emeritus by requesting this status, in writing, to the Secretary-Treasurer. 3. Junior Member any holder of a MD, PhD, DVM, or equivalent degree with demonstrated interest in the field of renal pathology as evidenced by enrollment in a renal pathology training program or research at the resident or fellow level. B. Membership Committee: Three members appointed by the President shall serve staggered terms of three years each. The Chair shall be the most senior member. C. Conferring of Membership: An application form (designed by the Membership Committee and approved by the Board of Directors) must be sent to the Secretary-Treasurer. The Membership Committee will review the applications and recommend approval or disapproval by the Board of Directors. All members of the Renal Pathology Club shall automatically become Regular Members following approval of the Bylaws. However, to retain their Membership, these Charter Members must submit a Membership application form within 3 months after receiving the form from the Membership Committee. Membership can be terminated by written resignation addressed to the President or Secretary-Treasurer. D. Rights of Members: Only Regular Members have the right to hold office and to vote. Each Regular Member has one vote. All Members have the right to attend the scientific sessions, and to participate in deliberations and discussions at the business meetings. No Member shall use the name, property, or the organization of the Society for personal benefit. Only currently elected officers shall represent the Society in official business. E. New members will be approved continuously throughout the year as new applications are submitted to the Membership Committee for consideration. The chair and two members will decide whether the applicant can be approved as a member. Only in the case of questions or problems will the application be

delayed until those issues can be discussed at the business meeting. The membership will be notified at the next business meeting of the Society of all new members accepted and their corresponding affiliations. Article IV Officers: A. Elected Officers: 1. President Term of office is one year. If the President vacates the office prematurely, the Vice-President succeeds. A President may not succeed him/herself in office. 2. Vice-President/President-Elect Vice-President serves one year as Vice-President and shall succeed as President. If this office is vacated prematurely, the senior Councillor shall become Vice-President. 3. Secretary-Treasurer Term of office is three years, with a maximum of two terms. If this office is vacated prematurely, the President shall appoint a replacement to serve until the next election of officers. 4. Councillors Three councillors serve staggered terms of three years each. If this office is vacated prematurely, the President shall appoint a replacement to serve until the next election of officers. B. Election of Officers: Any Society Regular Member is eligible to hold office. Nomination shall be recommended by a Nominating Committee and may be offered from the floor by any Regular Member. Election shall be by mail ballot. A majority vote of the responding members is required to elect an officer. C. Duties of Each Officer: 1. President The President shall be the principal executive officer of the Society. He/she shall preside at all meetings, serve as Chair of the Board of Directors, and take responsibility as a representative of the Society. The President officially receives donations, bequests, or gifts to the Society on behalf of the Society. The President shall appoint all standing committees, and replacements for Vice-Presidents and Councillors who vacate their offices prematurely. Ad hoc committees shall be appointed by the President. Before finishing his/her term, the President shall select a councillor who must be approved by the membership by a majority vote. The Board of Directors may be called upon to make recommendations for the new councillor. 2. Vice-President The Vice-President, in absence or incapacity of the President, shall perform the duties of the President. Further, the VicePresident shall serve on the Board of Directors. 3. Secretary-Treasurer The Secretary-Treasurer shall keep minutes of the Annual and Board of Directors meetings, distribute notices to members of Society, keep custody of documents of Society (including mortgages, deeds, and contracts that the Board of Directors has approved), serve on the Board of Directors, receive membership applications and dues, keep records of financial documents for governmental agencies, banks or other financial institutions with approval of the President for expenses used solely for the Society. All such disbursements shall be reported at the Annual Meeting. 4. Compensation The Officers shall not be paid for their services and shall not receive any

financial benefits from their service as officers of the Society. Article V Board of Directors: A. The Board of Directors shall consist of the current officers (i.e., President, Vice-President, SecretaryTreasurer, and three Councillors), the past President, and Chairmen of the standing committees (i.e., the chairmen of the Auditing [Secretary-Treasurer], Program, Education and Scientific, Nominating and Awards, Membership, Training Programs, Communications and Publications, and Research Committees). B. The Board of Directors shall: 1. Represent the Society in official business. 2. Carry out the directives and policies approved by the membership. 3. Organize and coordinate all meetings of the Society, in collaboration with the Education and Scientific Meeting Committee. 4. Exert leadership in the development and implementation of scientific programs according to the above stated objectives of Society. 5. Deal specifically with matters related to the incorporation of Society. Article VI Standing Committees (to be appointed by President): A. Program Committee The Committee shall be responsible for the design, organization and conduct of the scientific meeting sponsored by the Renal Pathology Society at the United States-Canadian Academy of Pathology and American Society of Nephrology and shall report to the Board of Directors. The Committee shall be composed of no less than three members. B. Education and Scientific Committee This Committee shall be responsible jointly with the Board of Directors for design, organization and conduct and other education efforts of the Society, and shall report to the Board of Directors. The Committee shall be composed of no less than three members. C. Membership Committee (See Article III.) D. Nominating and Awards Committee This Committee shall consist of three members. The past-President, acting as chair, and two additional acting Regular Members appointed by the current President. It shall be responsible for nominating new officers and selecting recipients for awards. E. Training Programs Committee This Committee shall encourage broader availability of training opportunities in renal pathology and help to upgrade their quality. Committee activities shall include collection and dissemination of information about training programs and identification and development of sources of support for trainees. F. Auditing Committee This Committee shall consist of three members. The Secretary-Treasurer, acting as chair, and two additional Regular Members appointed by the current president. It shall be responsible for an annual audit of Society financial affairs. G. Communications and Publications Committee This Committee shall oversee development of and monitor the Society presence on online computer resources and print publications of the Society. H. Research Committee This Committee shall plan and implement collaborative research projects involving the members of the RPS. Article VII Meetings: A. Scientific Meetings These meetings shall be held twice annually during the annual American Society

B.

C. D.

of Nephrology Meeting, and U.S. and Canadian Academy of Pathology Meeting. The time and place will be determined by the Board of Directors. Business Meeting This meeting shall be held annually during the ASN meeting. A quorum (i.e. 1/5 of total or 20 Regular Members) must be present to conduct business, but the scientific meeting may proceed in the absence of a quorum. Board of Directors Meeting This meeting shall be held twice annually during the USCAP and ASN meetings. Special Meetings These may be called as deemed necessary by the Board of Directors or President.

Article VIII Order of Business at the Annual Business Meeting: A. Determination of quorum B. Approval of the agenda C. Previous meeting minutes: Secretary-Treasurer D. Financial report: Secretary-Treasurer E. Reports of Committees F. Old business G. New business H. Announcement of new members and officers I. Adjournment Article IX Dues, Fees, and Compensation: A. Dues The annual dues shall be determined each year by the Board of Directors. Junior members are not required to pay Society’s dues while in training. B. Arrears Any member in arrears of dues for more than two years, failing satisfactory explanation, shall be dropped from membership. Such members may be reinstated on approval of the Membership Committee. C. Compensation No Society officer shall receive compensation for his/her services as such. The Board of Directors, acting by majority vote, may authorize or ratify the payment to any officer or member of reasonable compensation for expenses incurred on behalf of the Society in any capacity deemed necessary or advisable and in the best interest of the Society. Article X Amendments: Amendments to the Bylaws may be suggested in writing to the Secretary-Treasurer by any Regular Member at least two months prior to the Annual Business Meeting. If approved by the Board of Directors, this amendment needs to be accepted by a two-thirds majority mail vote of the Regular Members. Article XI Limitations and Dissolution: A. Limitations on Earnings No part of the net earnings of the Society shall inure to the benefit of, or be distributable to its members, trustees, directors, officers, or other private persons except that the Society shall be authorized and empowered to pay reasonable compensation for services rendered and to make payments and distributions in furtherance of the Society's purposes as set forth in Article II. B. Activities Not Permitted No substantial part of the activities of the Society shall be the carrying on of propaganda, or otherwise attempting to influence legislation, and the corporations shall not participate in or intervene in (including the publication or distribution of statements) of any political campaign on behalf of any candidate for public office. Notwithstanding any other provision of these bylaws, the corporation shall not carry on any other activity

C.

not permitted to be carried on (a) by a corporation exempt from federal income tax under Section 501 (c) (3) of the Internal Revenue Code of 1986 (or the corresponding provision of any future United States Internal Revenue Law) or (b) by a corporation, contributions to which are a deductible under Section 170 (c) (2) of the Internal Revenue Code of 1986 (or the corresponding provision of any future United States Internal Revenue Law). Dissolution Upon dissolution of the Society, the assets of the Society shall, after all its liabilities and obligations have been discharged or adequate provision made therefore, be distributed to the National Kidney Foundation if it is still in existence and is an exempt organization under Section 510 (c) (3) of the Internal Revenue Code or any successor section. If the National Kidney Foundation is not so qualified at the time of the dissolution of the corporation, the net assets shall be distributed to a corporation that is exempt under Section 501 (c) (3) of the Internal Revenue Code of 1986 or any successor section which is organized for purposes similar to those set out in Article II of these bylaws.

RENAL PATHOLOGY SOCIETY APPLICATION FORM The Renal Pathology Society is a nonprofit organization committed to increasing and disseminating knowledge about the pathology and pathophysiology of the kidney. Membership is open to any MD, PhD, DVM, or equivalent degree holder who has demonstrated accomplishments in nephropathology as determined by the Membership Committee under the direction of the Executive Committee
Please type or print.

1. Membership requires fulfillment of at least one of the following criteria: Criterion 1: Publication of at least one peer-reviewed article in the field of nephropathology. Criterion 2: Completion of a minimum of six months research or clinical training in nephropathology, e.g. during residency or postdoctoral fellowship. Criterion 3: Extensive clinical experience with the diagnostic pathologic evaluation of renal diseases Criterion 4: Extensive research experience on the pathology, pathophysiology, or pathogenesis of renal diseases. Indicate by number which of these criteria you fulfill _______________ 2. Fill in the following information:

Candidate Name Position Department Institution Street Address City, State, Country, Mailing Code

Telephone

FAX

E-mail Address

I certify that the information supplied is correct, and hold the Renal Pathology Society and its members free from any damage or complaint resulting from any action they may take in connection with this application.

Signature of Applicant

Date

Print name of RPS member who is sponsoring applicant.

Signature of RPS Member Date

3. Mail this form together with your current curriculum vitae to the Renal Pathology Society Chairman of the Membership Committee.

Renal Pathology Society Awards
YOUNG INVESTIGATOR AWARD The Renal Pathology Society Young Investigator Award was established to recognize and encourage excellence in the area of renal pathology in accordance with the goals of the Society. The recipients of the award are selected from those nominated based on the contents of abstracts that they have submitted as first author to the annual meeting of the ASN or USCAP. The awards, in the amount of $500 (US), are presented at the ASN and USCAP Meetings. Candidates must be nominated by a member of the Renal Pathology Society. The RPS member does not need to be a co-author of the submitted abstract but, if not, he or she should be from the same institution as the nominee. The research must have been carried out, while the candidate was a trainee (e.g., medical student, resident, fellow, graduate student) and not a faculty member. Nominations should be submitted to the Chair of the Nominating and Award Committee. Winners of the Renal Pathology Society Young Investigators Award Awarded at the 1995 USCAP Recipient Shane Meehan, M.D. Title Expression of TIA-1, a cytoxic I cell protein in renal allograft rejection. Early hypoxia induced loss of Na, K-ATpase polarity in proximal tubules is associated with specific calpain regulated fodrin processing. Modulation of plasminogen activator inhibitor-1 (PAI-1) in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. In vitro AL-amyloid formation by human mesangial cells (HMCs) is attenuated by chloroquine Variable region gene selection in murine antimyeloperoxidase (MPO) autoantibodies Expression of chemokines in murine crescentic glomerulonephritis Regression of glomerulosclerosis in aging by angiotensin II Type 1 receptor antagonist (AIIRA) is linked to inhibition of plasminogen activator inhibitor-1 (PAI-1) Blunted TGF-beta and ECM mRNA response during early acute rejection predicts for late development of chronic rejection Altered gene transcript Sponsor R. B. Colvin

1996 USCAP

Hugh B. Carey, M.D.

M. Kashgarian

1996 ASN

Tsuyoshi Oikawa, M.D.

A. Fogo

1997 USCAP

Jorge Isaac, M.D.

G. Herrera

1997 ASN 1998 USCAP 1999 USCAP 1999 ASN

Hitendra S. Jethwa No award given Peter Heeringa No award given

J.C. Jennette

J.C. Jennette

2000 USCAP

Li-jun Ma

A. Fogo

2000 ASN

No award given

2001 ASN

Michael Eikmans, Ph.D.

J. Bruijn

2003 USCAP

Adrian Suarez, M.D.

H. Liapis

profiles in congenitally obstructed human kidneys. Absence of integrin v6 decreases interstitial fibrosis but worsens glomerulosclerosis in remnant kidney mice Thymosin β4 is a marker or possibly even a contributor to glomerulosclerosis

2004 USCAP

Hai-Chun Yang

A. Fogo

2005 USCAP

Xiubin Liang

A. Fogo

THE JACOB CHURG AWARD The Jacob Churg Award, is presented annually at the USCAP meeting to an individual who has made major contributions to the field of nephropathology. The monetary component of the award is supported by a fund established by Barnert Hospital where Dr. Churg spent a substantial portion of his career on occasion of his retirement in 1996. Awardees are nominated by RPS members and selected from the nominations by the RPS Nominations and Awards Committee. Nominations, which should include a letter from the nominator and a C.V. of the nominee, should be sent to the Chair of this Committee. The First Jacob Churg Award was presented to J. Charles Jennette, M.D. at the 1997 USCAP Meeting in Orlando, FL The Second Jacob Churg Award was presented to Robert B. Colvin, M.D. at the 1998 USCAP Meeting in Boston, MA. The Third Jacob Churg Award was presented to Agnes Fogo, M.D. at the 1999 USCAP Meeting in San Francisco, CA. The Fourth Jacob Churg Award was presented to Vivette D’Agati, M.D. at the 2000 USCAP Meeting in New Orleans, LA. The Fifth Jacob Churg Award was presented to Melvin M. Schwartz, M.D. at the 2001 USCAP Meeting in Atlanta, GA. The Sixth Jacob Churg Award was presented to Fred Silva, M.D. at the 2002 USCAP Meeting in Chicago, IL. The Seventh Jacob Churg Award was presented to Charles Alpers, M.D. at the 2003 USCAP Meeting in Washington, DC. The Eighth Jacob Churg Award was presented to Michael Kashgarian, M.D. at the 2004 USCAP Meeting in Vancouver, Canada. The Ninth Jacob Churg Award was presented to Arthur Cohen, M.D. at the 2005 USCAP Meeting in San Antonio, TX.

Renal Pathology Fellowships and Program Directors
Program Site: Brigham and Women's Hospital Program Director: Helmut G. Rennke, M.D. Mailing Address: Department of Pathology Brigham & Women's Hospital 75 Francis Street Boston, MA 02115 Renal Pathology Laboratory VC14-219 College of Physicians & Surgeons of Columbia University 630 W 168th Street New York, NY 10032 Department of Pathology Cedars-Sinai Medical Center 8700 Beverly Blvd Los Angeles, CA 90048 Department of Pathology Barnert Hospital 680 Broadway Paterson, NJ 07514 Department of Pathology University of Alberta 5B4.02 Walter Mackenzie Centre Edmonton, Alberta Canada T6G 2R7 Department of Pathology University of North Carolina School of Medicine Chapel Hill, NC 27599-7525 Division of Hospital Pathology University of Washington Medical Center RC72, Rm BB 210J Seattle, WA 98195 Department of Pathology Vanderbilt University Medical Center, MCN C-3310 21st Avenue, S Nashville, TN 37232 Department of Pathology Yale University School of Medicine POB 208023 New Haven, CT 0650-8023 Department of Pathology LSUHSC - Shreveport 1501 Kings Highway Shreveport, LA 71130-3932 Department of Pathology 600 North Wolf Street Baltimore, MD 21205 Phone: FAX: Phone: (617) 732-6518 FAX: (617) 227-9015

College of Physicians and Surgeons

Vivette D'Agati, M.D.

Phone: (212) 305-6269 FAX: (212) 305-5498

Cedars-Sinai Medical Center

Arthur H. Cohen, M.D.

Phone: (310) 855-6621 FAX: (310) 967-0122

Barnert Hospital, NJ

Surya Seshan, M.D.

Phone: (201) 977-6770 FAX: (201) 977-6812

University of Alberta

Kim Solez, M.D.

Phone: (403) 492-2252 FAX: (403) 492-2253

University of North Carolina at Chapel Hill University of Washington

Volker Nickeleit, M.D

Phone: (919) 966-2421 FAX: (919) 966-4542

Charles E. Alpers, M.D.

Phone: (206) 548-6409 FAX: (206) 548-4928

Vanderbilt University

Agnes Fogo, M.D.

Phone: (615) 322-2102 FAX: (615) 322-3988

Yale University

Michael Kashgarian, M.D.

Phone: (203) 785-275 FAX: (203) 785-3348

Louisiana State University Health Sciences Center, Shreveport Johns Hopkins Medical Institutions

Guillermo Herrera, M.D.

Phone: (318) 675-4557 FAX: (318) 675-7662

Lorraine C. Racusen, M.D.

Phone: (410) 955-343 FAX: (410) 614-9011

Members who have information about training programs not listed here are encouraged to contact the Chair of the Training Programs Committee.

Officers*: President: Gloria Gallo Michael Kashgarian Vice-President: Michael Kashgarian Fred Silva Secretary/Treasurer: Charles Jennette Charles Jennette Councillors: Committees*: Membership: Arthur Cohen Vivette D'Agati Fred Silva Samy Iskandar Regina Verani Agnes Fogo Jay Bernstein Benjamin Spargo Jean Olson Robert Colvin Helmut Rennke Charles Alpers Fred Silva Gary Striker Seymour Rosen Charles Jennette Mark Weiss Cynthia Nast Arthur Cohen Vivette D'Agati Robert Colvin Regina Verani Agnes Fogo Stephen Bonsib

1993

1994

RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS + 1995 1996 1997 Fred Silva Vivette D'Agati Charles Jennette Arthur Cohen Robert Colvin Seymour Rosen Agnes Fogo Stephen Bonsib Allan Katz Vivette D'Agati Arthur Cohen Charles Jennette Robert Colvin Seymour Rosen Charles Alpers Stephen Bonsib Allan Katz Melvin Schwartz Fred Silva Surya Venkataseshan Mark Weiss Agnes Fogo Charles Alpers Helmut Rennke Michael Kashgarian Liliane Striker Robert Colvin Charles Jennette Luan Truong Dae Un Kim Cynthia Nast Kim Solez Gloria Gallo Seymour Rosen Charles Jennette Arthur Cohen Robert Colvin Charles Jennette Seymour Rosen Charles Alpers Melvin Schwartz Allan Katz Melvin Schwartz Walter Richardson Vivette D'Agati Seymour Rosen Agnes Fogo Cynthia Nast Michael Kashgarian Lillian Gaber Guillermo Herrera Tibor Nadasdy Regina Verani Charles Jennette Praveen Chander Isaac Stillman Samy Iskandar Kim Solez Charles Jennette optional optional

1998 Robert Colvin Seymour Rosen Charles Jennette Charles Alpers Melvin Schwartz Agnes Fogo Melvin Schwartz Walter Richardson Alex Magil Arthur Cohen Mark Haas Charles Alpers Helmut Rennke Lorraine Racusen Seymour Rosen Guillermo Herrera Terry Oberley Volker Nickeleit Charles Jennette Jean Olson Anthony Nicastri Samy Iskandar Kim Solez Charles Jennette Parmjeet Randhawa Stephen Bonsib

Nominating & Awards: Education & Scientific: Training Programs: Auditing:

Gloria Gallo Michael Kashgarian Manjeri Venkatachalam Melvin Schwartz Helmut Rennke Victoriano Pardo Charles Alpers Lorraine Racusen Mark Haas Fred Silva Gary Striker Arthur Cohen Charles Jennette Gary Hill Agnes Fogo Arthur Cohen Vivette D'Agati Jean Olson Cynthia Nast Helmut Rennke Tibor Nadasdy Charles Jennette Guillermo Herrera Dinyar Bhathena Cynthia Nast Kim Solez Robert Colvin Charles Alpers Charles Jennette

Communications & Publications:

Robert Colvin Cynthia Nast Byron Croker Byron Croker Mark Haas Tito Cavallo *Board of Directors - officers and chairs of standing committees: Terms are for one year except for Secretary/Treasurer - 3 year term (limited to 2 terms), Councillors (3 year term) and Membership Committee (3 year term, staggered with senior member chair). Chair of the Nominating and Awards committee is the Past President. Chair of the Auditing Committee is the Secretary/Treasurer. Membership, Auditing and Nominating & Awards Committees are limited to 3 members. Education & Scientific Meeting Committees must have at least three members. Other committees are at discretion of the President. + Steering Committee of the Renal Pathology Club 1992. These are the members who oversaw the transition from club to society. Jay Bernstein, M.D., Frank A. Carone, M.D., Arthur H. Cohen, M.D., Robert B. Colvin, M.D., Ramzi Cotran, M.D., Vivette D'Agati, M.D., Gloria R. Gallo, M.D., Gary S. Hill, M.D., J. Charles Jennette, M.D., Michael Kashgarian, M.D., Vivian Pinn-Wiggins, M.D., H.G. Rennke, M.D., Seymour Rosen, M.D., Benjamin Spargo, M.D., Liliane M. Striker, M.D., M.A. Venkatachalam, M.D.

Research:

RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS + Officers*: 1999 2000 2001 2002 Agnes Fogo Cynthia Nast Guillermo Herrera Charles Jennette Lorraine Racusen Helmut Rennke 2003 Cynthia Nast Charles Jennette Guillermo Herrera Lorraine Racusen Helmet Rennke Jan Bruijn 2004 Charles Jennette Lorraine Racusen Guillermo Herrera Jan Bruijn Steve Bonsib (2-year) Mark Haas (3-year)

President: Seymour Rosen Vice-President: Charles Alpers Secretary/Treasurer: Guillermo Herrera Councillors: Melvin Schwartz Agnes Fogo Cynthia Nast

Charles Alpers Melvin Schwartz Melvin Schwartz Agnes Fogo Guillermo Herrera Guillermo Herrera Agnes Fogo Cynthia Nast Charles Jennette Cynthia Nast Charles Jennette Lorraine Racusen

Committees*: Membership: Walter Richardson Alex Magil Mark Weiss Alex Magil Mark Weiss Suzanne Meleg-Smith Alex Magil Patrick Walker Mark Weiss Glen Markowitz Suzanne Meleg-Smith Maria Picken Charles Alpers Steve Bonsib Jan Bruijn Tito Cavallo Guillermo Herrera Byron Croker Melvin Schwartz Steve Bonsib Jan Bruijn Jan Bruijn Finn Reinholt Isaac Stillman Glen Markowitz Ian Roberts David Howell Agnes Fogo Jan Bruijn Glen Markowitz Jan Bruijn Mark Haas Terry Cook Maria Picken Ingeborg Bajema Zoltan Laszik Cynthia Nast Vivette D’Agati Melvin Schwartz Steve Bonsib Laura Barisoni Ian Roberts Agnes Fogo Samy Iskandar Robert Colvin Guillermo Herrera Randy Hennigar Sally Self Suzanne Meleg-Smith Luiz Moura Kensuke Joh

Nominating & Awards: Education & Scientific:

Robert Colvin Seymour Rosen Charles Alpers Patrick Walker Michael Kashgarian Alex Magil Arthur Cohen Guillermo Herrera Lorraine Racusen Seymour Rosen Lorraine Racusen Tibor Nadasdy Regina Verani Guillermo Herrera Charles Jennette Jan Bruijn Paul Shanley Samy Iskandar Kim Solez Charles Jennette Parmjeet Randhawa Stephen Bonsib Cynthia Nast Franco Ferrario James Pullman Charles Jennette Agnes Fogo Melvin Schwartz

Training Programs:

Lorraine Racusen Lorraine Racusen Lorraine Racusen Lorraine Racusen Michael Kashgarian Michael Kashgarian Mike Kashgarian Surya Seshan Fred Silva Hermann-Josef Gröne Hermann-Josef Gröne Franco Ferrario Hermann-Josef Gröne Guillermo Herrera Mary Ann Sens Maria Picken Samy Iskandar Kim Solez Helen Liapis Jan Bruijn Cynthia Nast Franco Ferrario James Pullman Guillermo Herrera Mark Haas Surya Seshan Samy Iskandar Kim Solez Helen Liapis Jan Bruijn James Pullman Franco Ferrario Tibor Nadasdy Guillermo Herrera Carrie Phillips Steve Bonsib Guillermo Herrera Joseph Zhou Mary Fidler

Auditing:

Communications & Publications:

Suzanne Meleg-Smith Suzanne Meleg-Smith Kim Solez Kim Solez Helen Liapis Helen Liapis

Research:

James Pullman Franco Ferrario Tibor Nadasdy

Patrick Walker James Pullman Peter Furness

Patrick Walker Terry Cook Mark Haas

RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS 2003 Program Committee (begun in 2003) Steve Bonsib Helmut Rennke Laura Barisoni Lois Arend 2004 Sharan Singh Surya Seshan Volker Nickeleit Kenneth Bernstein

RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS
2005 President: Lorraine Racusen Vice-President: Jan Bruijn Secretary/Treasurer: Guillermo Herrera Councillors: Committees*: Membership: Steve Bonsib Mark Haas Surya Seshan Maria Picken Ingeborg Bajema Zoltan Laszik Charles Jennette Michael Hughson Arthur Abt Ian Roberts Laura Barisoni Steve Bonsib Agnes Fogo Robert Colvin Samy Iskandar Pat Walker Serena Bagnasco Terry Cook Mark Haas Carrie Phillips Luan Truong Shamila Mauiyyedi Regina Verani Suzanne Meleg-Smith Peter Furness Kensuke Joh Luiz Moura Jean Olson Volker Nickeleit Charles Alpers Jan Bruijn Hermann-Josef Grone

Nominating & Awards: Education & Scientific: Training Programs: Research:

Auditing:

Communications & Publications:

Program Committee (begun in 2003)

Date 11/19/78

Moderator (s) Michael Kashgarian, M.D.

Speakers and Topics of Renal Pathology Club Sponsored Sessions Session Topic Speakers Titles Idiopathic Nephrotic Syndrome With "Nil" Disease, Minimal Changes, Focal Segmental or Global Glomerulosclerosis Jay Bernstein, M.D. Michael Kashgarian, M.D. Peter Burkholder, M.D. Alfred Michael, M.D. Renee Habib, M.D. Rapidly Progressive Glomerulonephritis William Couser, M.D. Curtis Wilson, M.D. Robert Atkins, M.D. A Report from the International Study of Kidney Disease in Children Clinical-Pathologic Correlations Evidence for Immunologic Mechanisms Experimental Models New Classification of Glomerulonephritis Immunologic Spectrum of RPGN Studies on Anti-GBM Antibodies & Nephrotoxic Antigens Macrophages in Crescentic GN The Pleomorphic Renal Pathology in "Myeloma" and Other Dysproteinemias Ultrastructural Glomerular and Tubular Lesions in Plasma Cell Dyscrasias Renal Handling of Light Chain and Other Low Molecular Weight Proteins Experimental Models of "Myeloma" Kidney Basic Biology of the Endothelium Regulation of Platelet-Vessel Wall Interactions Coagulation Processes in Renal Glomerulus Relations of Intravascular Coagulation and Endothelial Damage to Hypertension Pathophysiology of Human Cystic Disease Tubular Cell and Basement Membrane Changes in Experimental Cystic Disease Epithelial Hyperplasia in the Pathogenesis of Renal Cystic Disease Mechanisms of Graft Rejection: Phenotype and Function of Infiltrating Cells

11/18/79

Ramzi S. Cotran, M.D. Robert T. McCluskey, M.D.

11/23/80

Jacob Churg, M.D. Conrad L. Pirani, M.D.

The Kidney in Dysproteinemias

Liliane Morel-Maroger, M.D. Fred G. Silva, M.D. Thomas Maack, M.D. David Clyne, M.D.

11/22/81

Ramzi S. Cotran, M.D. Robert H. Heptinstall, M.D.

Endothelium, Hemostasis and Intra-vascular Michael A. Gimbrone, Jr., M.D. Coagulation in the Kidney Giuseppe Remuzzi, M.D. Jacob Churg, M.D. Robert H. Heptinstall, M.D. Renal Cystic Disease Jared Grantham, M.D. Frank A. Carone, M.D. Andrew P. Evan, M.D.

12/12/82

Frank A. Carone, M.D.

12/15/85

Benjamin H. Spargo, M.D.

Pathology of Renal Transplantation

Robert B. Colvin, M.D.

Richard K. Sibley, M.D 12/7/86 Liliane J. Striker, M.D. Diabetic Kidney Disease Byron P. Croker, M.D., Ph.D. Bryan Myers, M.D. Peter Bennett, M.D. Helmut Rennke, M.D. Conrad Pirani, M.D. 12/13/87 Frank A. Carone, M.D. Current Concepts in the Pathogenesis of Polycystic Kidney Disease (PKD) Frank A. Carone, M.D. Yashpal Kanwar, M.D., Ph.D. James McAteer, Ph.D. Kenneth D. Gardner, Jr., M.D. Jacob Churg, M.D. J. Charles Jennette, M.D. C.M. Lockwood, M.D. Ramzi S. Cotran, M.D. 12/3/89 Michael Kashgarian, M.D. Glomerular Mesangial Disease David H. Lovett, M.D. Steven Emancipator, M.D. Melvin M. Schwartz, M.D. Jean L. Olson, M.D. Giuseppe Andres, M.D. Seymour Rosen, M.D. Richard J. Glassock, M.D. J. Charles Jennette, M.D. Arthur Cohen, M.D. Robert Colvin, M.D. Barbara Bane, M.D. 11/17/91 Vivette D'Agati, M.D. Symposium on Cyclosporine Toxicity Michael Mihatsch, M.D. Giuseppe Remuzzi, M.D. William Bennett, M.D.

Renal Allograft Histo- and Immunopathology in Cyclosporine Treated Recipients Glomerulonephritis in Renal Allografts Relationship Between Structure and Function in Human Diabetes Epidemiology of Diabetic Nephropathy in the Pima Indian Population Nature of Progression of Glomerular Lesions in Diabetic Rats - Relationship with Human Disease The Basement Membrane in Diabetic Nephropathy Role of Epithelial Cell in PKD Role of Tubular Basement Membrane in PKD Factors Controlling Cyst Growth Environmental Factors in PKD Historical Overview Crescentic Necrotizing Glomerulonephritis without Immune Complexes: An Expression of Vasculitis Anti-Neutrophil Cytoplasmic Antibodies Pathogenesis of Vasculitis Pathobiology of Glomerular Mesangium IgA Nephropathy Role of Mesangium in Glomerular Sclerosis Hypertension and Glomerular Sclerosis Pathogenesis, an Overview Morphologic Evolution Clinical Update Anti-Neutrophil Cytoplasmic Autoantibodies HIV and the Kidney Recent Advances in the Pathogenesis of Renal Allograft Rejection Renal Cell Carcinoma: Review and Update Morphologic Features of Cyclosporine Nephrotoxicity Pathogenesis of Cyclosporine Nephrotoxicity Clinical Update of Cyclosporine Nephrotoxicity

12/11/88

Seymour Rosen, M.D.

Vasculitis: Current Concepts

12/2/90

Jay Bernstein, M.D.

Membranous Glomerulonephritis Revisited Current Topics in Renal Pathology

3/17/91

Michael Kashgarian, M.D. Fred Silva, M.D.

Date 3/15/92

Moderator (s) Jay Bernstein, M.D.

Session Topic Current Topics in Renal Transplantation, Tumors, Vascular Disease and Glomerulonephritis

Speakers Cynthia C. Nast, M.D. J. Bruce Beckwith, M.D. Vivette D'Agati, M.D. Melvin M. Schwartz, M.D. Gary S. Hill, M.D. Agnes Fogo, M.D. Stephen Korbet, M.D. Gloria Gallo, M.D. Nancy L. Harris, M.D. Michael E. Lamm, M.D. Jay Bernstein, M.D. Vivette D'Agati, M.D. Guiseppe Remuzzi, M.D. Michael Gimbrone, M.D. Nancy Harris, M.D. Kim Solez, M.D. Robert McCluskey, M.D. Charles Alpers, M.D.

Titles Renal Allograft Evaluation by Aspiration Biopsy Wilm's Tumor and Nephroblastomatosis Hemolytic-Uremic Syndrome Lupus Nephritis: The Results of the Lupus Collaborative Trial Pathology of FSGS The Pathogenesis of FSGS The Clinical Management of FSGS Non-amyloid Fibrillary Glomerulopathies Post-transplant Lymphoproliferative Disorders Update on IgA Nephropathy Glomerulocystic Disease Pathology and Pathophysiology Clinical Aspects Endothelial Biology Post-transplant Lymphoproliferative Disorder Pathology and Pathogenesis of Acute Tubular Injury Vasculitis: Pathology and Pathogenesis Cryoglobulinemia and Hepatitis C Virus The Renal Basement Membranopathies Type IV Collagen: Molecular Structure and Role in Glomerular Disease Cloning of the Alport's and Polycystic Kidney Disease Genes: Clinical Aspects Current Concepts in Acute Renal Failure Mechanisms of Tubulointerstitial Injury and Fibrosis Tubular Cell Proliferation in Health and Disease Pathobiology of the Vascular Wall in Hypertension New Genetic Models of Experimental Hypertension Renal Pathology of Hypertension: a Classical

11/15/92

Arthur Cohen, M.D.

Focal Segmental Glomerulosclerosis

3/14/93

Melvin M. Schwartz, M.D.

Current Topics in Glomerular Diseases and Transplantation

11/14/93

Robert Colvin, M.D.

Hemolytic-Uremic Syndrome

3/13/94

Robert Colvin, M.D.

Current Topics in Renal Pathology

10/24/94

Charles Alpers, M.D.

Familial Renal Disease

Arthur Cohen, M.D. Billy Hudson, Ph.D. Stephen Reeders, M.D.

3/12/95

Charles Alpers, M.D.

Pathobiology of the Tubules and Interstitium Michael Kashgarian, M.D. Alison A. Eddy, M.D. The Kidney in Hypertension Fred Silva, M.D. Leopoldo Raij, M.D. Theodore Kurtz, M.D. Jean Olson, M.D.

11/5/95

Vivette D'Agati, M.D.

Date 3/24/96

Moderator (s) Arthur Cohen, M.D.

Session Topic Advanced Renal Disease and Renal Transplantation

Speakers Mark Weiss, M.D. Fred Sanfilippo, M.D. Richard K. Sibley, M.D. Stephen Bonsib, M.D.

Titles View Remodeled Acquired Renal Cystic Disease and End-Stage Kidneys Current Concepts in Transplant Immunology and Pathobiology Pathology of the Transplanted Kidney: Update on Rejection and Classification Schemes Recurrent Diseases in the Transplanted Kidney Mechanisms Underling Diabetic Nephropathy Renal Pathology of Diabetes Clinical Aspects of Diabetic Nephropathy Fine Needle Aspiration in Diagnosis of Renal Diseases Renal Vasculopathies of Essential Hypertension New Insights and Challenges Molecular Markers in Acute Renal Failure New Approaches in Renal Pathology: Transcriptional Factors, Functional Surface Molecules and Cytokine Products in Inflammatory and Immunologic Injuries Pathogenetic Considerations Pathologic Features Clinical Aspects, Risk Factors, and Therapy Epstein-Barr Virus Hemorrhagic Diseases CMV and BK Virus Adenovirus Immunoregulatory Genes and Their Role in Islet-cell Transplantation, Autoimmunity and Viral Vector Design The Multifactorial Nature of Acute Renal Failure: The Lessons Learnt from Rhabdomyolysis Models of Acute Tubular Necrosis: A Perspective Cell Biology and Molecular Mechanisms of Tubular Injury The Importance of the Classification of Renal Neoplasms

11/3/96

Agnes Fogo, M.D.

Diabetic Nephropathy

Kumar Sharma, M.D. Liliane Striker, M.D. Hans-Henrik Parving, M.D. Cynthia Nast, M.D. Richard E. Tracy, M.D. Lorraine Racusen, M.D. Wayne Hancock, M.D.

3/2/97

Agnes Fogo, M.D.

New Approaches to Renal Biopsy Diagnosis and Prognosis

11/2/97

Cynthia C. Nast, M.D.

Chronic Allograft Rejection

Leendert C. Paul, M.D. Hallgrimur Benediktsson, M.D. Bertram L. Kasiske, M.D. Tibor Nadasdy, M.D. Sherif R. Zaki, M.D. Roger Smith, M.D. Marshall S. Horowitz, M.D.

3/1/98

Cynthia C. Nast, M.D. Sylvana M. Tuur-Saunders

Viruses and the Kidney (Co-sponsor with Binford-Dammin Society)

10/25/98

Helmut Rennke, M.D.

Advances in the Pathobiology of Acute Renal Failure

Richard Zager, M.D. Seymour Rosen, M.D. Manjeri Venkatachalam, M.D.

3/21/99

Seymour Rosen, M.D.

New Perspectives in Kidney Diseases

John Eble, M.D.

Vivette D’Agati, M.D. Helmut G. Rennke, M.D. J. Charles Jennette, M.D. J. Charles Jennette, M.D.

11/6/99

Arthur Cohen, M.D.

Antineutrophil Cytoplasmic Antibodies (ANCA) in Renal Disease: Is It Important Pathogenically or Is It an Epiphenomenon? Caroline O.S. Savage, M.D. John L. Niles, M.D. Disorders Affecting the Kidney and Liver Together Wayne Grody, M.D. Stephen A. Geller, M.D. Glen S. Markowitz, M.D.

3/26/00

Arthur Cohen, M.D. Stephen A. Geller, M.D.

10/14/00

J. Charles Jennette, M.D. Surya Seshan, M.D.

Lupus Nephritis: Pathogenesis, Pathology, Michael Madaio, M.D. and Optimal Therapy Vivette D’Agati, M.D. Edmund Lewis, M.D.

3/4/01

J. Charles Jennette, M.D.

Advances in Renal Pathology and Pathophysiology

Gary Hill, M.D. Joseph P. Grande, M.D. Helen Liapis, M.D. Andrey Shaw, M.D.

10/14/01 Tito Cavallo, M.D. Mark Haas, M.D. 2/24/02 Tito Cavallo, M.D. Byron Croker, M.D.

Renal AL-amyloidogenesis: New insights into Mechanisms and Therapy Hereditary Nephropathies

Guillermo A. Herrera, M.D. Raymond L. Comenzo, M.D. William L. Clapp, M.D. Billy G. Hudson, M.D. Clifford E. Kashtan, M.D. Paul S. Thorner, M.D. Andrew J. Rees, M.D. Raghu Kalluri, Ph.D.

11/4/02 William Couser, M.D. Roger C. Wiggins, M.D.

New Approaches in the Treatment of Crescentic Glomerulonephritis

The Nature of Nil Disease, Focal Glomerulosclerosis, and Collapsing Glomerulopathy Thin Glomerular Basement Membrane Disease Insights into Systemic Vasculitis Serologic and Pathologic Diseases of ANCAAssociated Renal Diseases Pathogenesis of ANCA-Related Renal Injury Utility of ANCA in Long-Term Management and in the Transplant Setting The Genetics of Autosomal Dominant Polycystic Kidney Disease Ductal Plate Disorders of the Liver New Animal Models of Autosomal Dominant Polycystic Kidney Disease Pathogenesis of Lupus Nephritis: Therapeutic Implications Pathologic Characterization and Classification of Lupus Nephritis Clinical Management of Lupus Nephritis: Impact of Pathologic Findings The Pathology of Lupus Nephritis: New Insights Omega-3 Fatty Acids: Effects on the Pathogenesis and Progression of Glomerulonephritis Molecular Pathogenesis of Renal Fibrosis New Insights into Glomerular Podocyte Biology and Pathophysiology Understanding the Pathogenesis of Renal ALamyloidosis The tropism of organ involvement in ALamyloidosis Introduction to Hereditary Nephropathies Molecular Basis of Alport’s Syndrome: Organization, Assembly and Defects in Type IV Collagen Alport’s Syndrome and Thin Basement Membrane Nephropathy: Genes, Proteins and Clinico-pathologic Correlations Alport’s Syndrome: Prospect for Gene Therapy Macrophages in Renal Inflammation Role of Novel Glomerular Basement Membrane

Peter G. Tipping, M.D. Charles D. Pusey, FRCP John Tomaszewski, M.D. Glen Markowitz, M.D. Dr. Jeffery Kopp Dr. Robert Star 11/15/03 Stephen Bonsib, M.D. Surya Seshan, M.D. An SLE Update: Clinicopathologic Correlations J. Charles Jennette, M.D. Lee A. Hebert, M.D. Howard A. Austin, M.D. 3/7/04 Sharan K. Singh, M.D. Update on Renal Transplant Pathology Volker Nickeleit, M.D. Robert B. Colvin, M.D. Lorraine C. Racusen, M.D. Neeraja Kambham, M.D. 10/29/04 Robert B. Colvin, M.D. Harsharan K. Singh, M.D. Donor Pretreatment and Protocol Biopsies of Kidney Allografts: A Critical Update Lorraine C. Racusen, M.D. Volker Nickeleit, M.D., Ph.D. David N. Rush, M.D. Alan H. Wilkinson, M.D. 2/27/05 Luan D. Truong, M.D. Pathobiology of the Podocyte Peter Mundel, M.D. Vivette D’Agati, M.D. Laura Barisoni, M.D. Agnes B. Fogo, M.D.

3/23/03 Stephen Bonsib, M.D.

Tubulo-Interstitial Nephritis: Diagnostic Issues, Mechanisms, and Methodologies

Antigens in Glomerulonephritis Cell-Mediated Aspects of Crescentic Glomerulonephritis: Contributions of Leukocytes and Intrinsic Renal Cells Therapies for Crescentic Glomerulonephritis Acute Interstitial Nephritis: Infection, Rejection, and Autoimmune Drug-Induced Tubulointerstitial Nephropathies: New Insights and Old Concepts Tubular Epithelial Cell Injury and Interstitial Fibrosis New Methods to Diagnose Kidney Disease: Lasers, Chips, & Dendrimers and Beyond New Concepts in the Classification of SLE Nephritis: Pathological Aspects Clinical Implications from the Reclassification of the Kidney Biopsy in SLE SLE Nephritis in Different Clinical Populations: Therapeutic and Prognostic Considerations The Importance of Routinely Evaluating C4d in Renal Allograft Biopsy Specimens New Insights on Chronic Allograft Nephropathy/Chronic Rejection Practical Update on the Pathologic Classification of Renal Transplant Pathology Including Criteria for Antibody Mediated Rejection Gene Microarray Analysis of Acute Renal Allograft Rejection New Markers of Rejection Baseline (Zero Hour) Biopsies Protocol Biopsies and Follow-up Biopsies: A Debate – Pro Protocol Biopsies and Follow-up Biopsies: A Debate – Con Novel Insight Into the Pathogenesis of Nephrotic Syndrome Primary and Secondary Focal Segmental Glomerulosclerosis: Morphologic Classification and Clinical Correlation Modulation of Podocyte Phenotype and the Emerging Role of Biomarkers in Podocytopathies Progression and Potential Regression of

Glomerulosclerosis


				
Lingjuan Ma Lingjuan Ma
About